296 related articles for article (PubMed ID: 35511379)
1. Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis.
Sharma T; Gupta A; Chauhan R; Bhat AA; Nisar S; Hashem S; Akhtar S; Ahmad A; Haris M; Singh M; Uddin S
Cancer Metastasis Rev; 2022 Jun; 41(2):281-299. PubMed ID: 35511379
[TBL] [Abstract][Full Text] [Related]
2. Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis.
Li Y; Wei B; Xue X; Li H; Li J
Cancer Biol Med; 2023 Oct; 21(2):163-74. PubMed ID: 37817487
[TBL] [Abstract][Full Text] [Related]
3. Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.
Neto AG; Whitaker A; Pei Z
Semin Oncol; 2016 Feb; 43(1):86-96. PubMed ID: 26970127
[TBL] [Abstract][Full Text] [Related]
4. Impact of inflammation-metaplasia-adenocarcinoma sequence and inflammatory microenvironment in esophageal carcinogenesis using surgical rat models.
Miyashita T; Tajima H; Shah FA; Oshima M; Makino I; Nakagawara H; Kitagawa H; Fujimura T; Harmon JW; Ohta T
Ann Surg Oncol; 2014 Jun; 21(6):2012-9. PubMed ID: 24526548
[TBL] [Abstract][Full Text] [Related]
5. Dynamic switch of immunity and antitumor effects of metformin in rat spontaneous esophageal carcinogenesis.
Takei R; Miyashita T; Takada S; Tajima H; Ninomiya I; Takamura H; Fushida S; Harashima A; Munesue S; Yagi S; Inaki N; Ohta T; Yamamoto Y
Cancer Immunol Immunother; 2022 Apr; 71(4):777-789. PubMed ID: 34398301
[TBL] [Abstract][Full Text] [Related]
6. Complex Role of Microbiome in Pancreatic Tumorigenesis: Potential Therapeutic Implications.
Amara S; Yang LV; Tiriveedhi V; Muzaffar M
Cells; 2022 Jun; 11(12):. PubMed ID: 35741028
[TBL] [Abstract][Full Text] [Related]
7. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma.
Lv J; Guo L; Liu JJ; Zhao HP; Zhang J; Wang JH
World J Gastroenterol; 2019 May; 25(18):2149-2161. PubMed ID: 31143067
[TBL] [Abstract][Full Text] [Related]
8. Discovery of an interplay between the gut microbiota and esophageal squamous cell carcinoma in mice.
Cheung MK; Yue GGL; Tsui KY; Gomes AJ; Kwan HS; Chiu PWY; Lau CBS
Am J Cancer Res; 2020; 10(8):2409-2427. PubMed ID: 32905484
[TBL] [Abstract][Full Text] [Related]
9. The Role of Microbiota in the Pathogenesis of Esophageal Adenocarcinoma.
Gillespie MR; Rai V; Agrawal S; Nandipati KC
Biology (Basel); 2021 Jul; 10(8):. PubMed ID: 34439930
[TBL] [Abstract][Full Text] [Related]
10. Subcloning and characterization of highly metastatic cells derived from human esophageal squamous cell carcinoma KYSE150 cells by in vivo selection.
Okuda M; Inoue J; Fujiwara N; Kawano T; Inazawa J
Oncotarget; 2017 May; 8(21):34670-34677. PubMed ID: 28410227
[TBL] [Abstract][Full Text] [Related]
11. No difference in 4-nitroquinoline induced tumorigenesis between germ-free and colonized mice.
Zhou YX; Fuentes-Creollo G; Ponce F; Langley SA; Jen KY; Celniker SE; Mao JH; Snijders AM
Mol Carcinog; 2019 May; 58(5):627-632. PubMed ID: 30632250
[TBL] [Abstract][Full Text] [Related]
12. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
13. Esophageal Dysbiosis in Achalasia and Cancer Development: A Critical Review.
Tustumi F; Arienzo VP; Sunye IR; Lucas PFS; Colonno BB; Quintas JG; Lisboa EN; Szor DJ
Genes (Basel); 2023 Jul; 14(8):. PubMed ID: 37628573
[TBL] [Abstract][Full Text] [Related]
14. The tumor microenvironment in esophageal cancer.
Lin EW; Karakasheva TA; Hicks PD; Bass AJ; Rustgi AK
Oncogene; 2016 Oct; 35(41):5337-5349. PubMed ID: 26923327
[TBL] [Abstract][Full Text] [Related]
15. Molecular interplay of pro-inflammatory transcription factors and non-coding RNAs in esophageal squamous cell carcinoma.
Sundaram GM; Veera Bramhachari P
Tumour Biol; 2017 Jun; 39(6):1010428317705760. PubMed ID: 28618941
[TBL] [Abstract][Full Text] [Related]
16. Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma.
Sugihara H; Ishimoto T; Miyake K; Izumi D; Baba Y; Yoshida N; Watanabe M; Baba H
Int J Mol Sci; 2015 Nov; 16(11):27824-34. PubMed ID: 26610479
[TBL] [Abstract][Full Text] [Related]
17. The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development.
Doocey CM; Finn K; Murphy C; Guinane CM
BMC Microbiol; 2022 Feb; 22(1):53. PubMed ID: 35151278
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus.
Hezova R; Kovarikova A; Srovnal J; Zemanova M; Harustiak T; Ehrmann J; Hajduch M; Svoboda M; Sachlova M; Slaby O
Diagn Pathol; 2015 Apr; 10():42. PubMed ID: 25928282
[TBL] [Abstract][Full Text] [Related]
19. Differential response of esophageal cancer cells to particle irradiation.
Hartfiel S; Häfner M; Perez RL; Rühle A; Trinh T; Debus J; Huber PE; Nicolay NH
Radiat Oncol; 2019 Jul; 14(1):119. PubMed ID: 31286978
[TBL] [Abstract][Full Text] [Related]
20. The inflammatory microenvironment and microbiome in prostate cancer development.
Sfanos KS; Yegnasubramanian S; Nelson WG; De Marzo AM
Nat Rev Urol; 2018 Jan; 15(1):11-24. PubMed ID: 29089606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
